Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases

British Journal of Cancer

Volumn 104, Issue 6, 2011, Pages 1007-1012

  Mole, D J ^a,b   O'Neill, C ^c   Hamilton, P ^c   Olabi, B ^a   Robinson, V ^a   Williams, L ^a   Diamond, T ^c   El Tanani, M ^d   Campbell, F C ^d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

colorectal cancer; hepatectomy; metastasis; osteopontin

Indexed keywords

OSTEOPONTIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR ETS 2; TRANSCRIPTION FACTOR PEA3; TRANSCRIPTION REGULATORY COMPLEX; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; MALE; METASTASIS POTENTIAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

AGED; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; OSTEOPONTIN; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEIN C-ETS-2; TRANSCRIPTION FACTORS;

EID: 79952704799     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.33     Document Type: Article

References (19)

1. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D, Yeatman TJ (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94: 513-521 (Pubitemid 34411290)
2. Costello SS, Johnston DJ, Dervan PA, O'Shea DG (2003) Development and evaluation of the virtual pathology slide: a new tool in telepathology. J Med Internet Res 5: e11
3. El-Tanani M, Platt-Higgins A, Rudland PS, Campbell FC (2004) Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. J Biol Chem 279: 20794-20806 (Pubitemid 38656476)
4. El-Tanani MK, Campbell FC, Kurisetty V, Jin D, McCann M, Rudland PS (2006) The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev 17: 463-474 (Pubitemid 44793123)
5. El-Tanani MK, Jin D, Campbell FC, Johnston PG (2010) Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression. Oncogene 29: 752-762
6. Ellis CM, Dyson MJ, Stephenson TJ, Maltby EL (2005) HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques. J Clin Pathol 58: 710-714 (Pubitemid 40956824)
7. Eschrich S, Yang I, Bloom G, Kwong KY, Boulware D, Cantor A, Coppola D, Kruhoffer M, Aaltonen L, Orntoft TF, Quackenbush J, Yeatman TJ (2005) Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 23: 3526-3535
8. Fidler IJ (2002) Critical determinants of metastasis. Semin Cancer Biol 12: 89-96 (Pubitemid 34680737)
9. Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, Ledermann J, Primrose JN, Parks RW (2006) Guidelines for resection of colorectal cancer liver metastases. Gut 55(Suppl 3): iii1-iii8 (Pubitemid 44085662)
10. Irby RB, McCarthy SM, Yeatman TJ (2004) Osteopontin regulates multiple functions contributing to human colon cancer development and progression. Clin Exp Metastasis 21: 515-523
11. Liu Y, Borchert GL, Phang JM (2004) Polyoma enhancer activator 3, an ets transcription factor, mediates the induction of cyclooxygenase-2 by nitric oxide in colorectal cancer cells. J Biol Chem 279: 18694-18700 (Pubitemid 38623293)
12. Molnar B, Berczi L, Diczhazy C, Tagscherer A, Varga SV, Szende B, Tulassay Z (2003) Digital slide and virtual microscopy based routine and telepathology evaluation of routine gastrointestinal biopsy specimens. J Clin Pathol 56: 433-438 (Pubitemid 36724211)
13. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790 (Pubitemid 27136715)
14. Nakamura T, Fidler IJ, Coombes KR (2007) Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment. Cancer Res 67: 139-148 (Pubitemid 46142769)
15. Polakis P (2000) Wnt signaling and cancer. Genes Develop 14: 1837-1851 (Pubitemid 30639518)
16. Sato M, Morii E, Komori T, Kawahata H, Sugimoto M, Terai K, Shimizu H, Yasui T, Ogihara H, Yasui N, Ochi T, Kitamura Y, Ito Y, Nomura S (1998) Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/ CBFA1 and ETS1 in the skeletal tissues. Oncogene 17: 1517-1525 (Pubitemid 28472756)
17. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343: 1405-1410 (Pubitemid 24167517)
18. Steinberg DM, Ali SZ (2001) Application of virtual microscopy in clinical cytopathology. Diagnostic Cytopathol 25: 389-396 (Pubitemid 33110931)
19. Xing X, Wang SC, Xia W, Zou Y, Shao R, Kwong KY, Yu Z, Zhang S, Miller S, Huang L, Hung MC (2000) The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis. Nat Med 6: 189-195 (Pubitemid 30082364)